'Unproven treatment of spinal injuries can cause paralysis'

Image
IANS New Delhi
Last Updated : Apr 24 2014 | 11:04 PM IST

The rampant unauthorised and unproven stem cell transplant for spinal cord injury can leave a person paralysed below the level of injury, health experts said Thursday.

Issuing a statement to caution people about such practices and create awareness on the issue, the Association of Spine Surgeons of India (ASSI) said: "There is an urgent need to create awareness on the issue, and advise the spinal cord injured and their families to make informed decisions regarding the plethora of 'effective' stem transplant treatments being offered across the world."

"Over the past decade, various clinics in India and abroad have started offering experimental treatments, often involving transplants of stem cells, which are advertised as having beneficial effects, even though there is little or no evidence supporting such claims," said ASSI president Ram Chaddha.

He added these stem cells transplant procedures attempt to establish credibility by citing experimental studies that have no direct relation to the spinal cord injuries.

Sajan Hegde, consultant spine surgeon at Apollo Hospital who also heads its orthopaedics department, said the only accurate way to determine that a treatment is beneficial is to carry a properly designed study with an appropriate control group.

"It is important to conduct valid clinical trials to evaluate whether stem cell and cellular transplant can be offered as a valid option after the spinal cord injury. Some properly conducted trials are now being under taken, but it is advisable to wait for the results from these objective studies," he said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 24 2014 | 10:56 PM IST

Next Story